This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Most-Shorted Biotech Stocks of 2013

4. Ziopharm Oncology (ZIOP)

Short interest: 33% of float ^NBI Chart ^NBI data by YCharts

Shorts say: R.J. Kirk is full of $%^&.

3. Dendreon (DNDN)

Short interest: 35% of float ^NBI Chart ^NBI data by YCharts

Shorts say: Going out of business.

2. Spectrum Pharmaceuticals (SPPI)

Short interest: 37% of float ^NBI Chart ^NBI data by YCharts

Shorts say: Is Raj still CEO? He is? Short!

And the most highly shorted biotech stock in 2013 is...

3 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG
ARNA $4.31 -0.69%
DNDN $0.06 -6.02%
MNKD $4.37 4.55%
SNSS $2.30 1.77%
SRPT $13.27 4.28%

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs